{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-048888","form_type":"8-K","ticker":"VIVS","cik":"0001497253","company_name":"VivoSim Labs, INC.","filed_at":"2025-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.458729+00:00","generated_at":"2026-05-23T23:30:55.172156+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Organovo reports ~$11.3M cash, expects to meet Nasdaq listing requirements","bullets":["Preliminary cash and equivalents ~$11.3M as of March 31, 2025; Q4 net cash utilization ~$2.0M-$2.2M.","Stock closed above $1.00 minimum bid since March 21, 2025; company expects to meet continued listing criteria.","Hearings Panel granted exception until April 15, 2025 to demonstrate compliance with bid price and equity rules.","Believes it meets $2.5M stockholders' equity after $9M upfront from FXR asset sale to Eli Lilly.","Expects potential $5M milestone within 12 months from FXR program upon Phase 2 trial commencement."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-048888","json":"https://secwatch.observer/filing/0000950170-25-048888.json","markdown":"https://secwatch.observer/filing/0000950170-25-048888.md","text":"https://secwatch.observer/filing/0000950170-25-048888.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1497253/000095017025048888/0000950170-25-048888-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1497253/000095017025048888/onvo-20250402.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T23:30:55.172156+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}